Literature DB >> 12618931

140 consecutive cases of minimally invasive, radio-guided parathyroidectomy: lessons learned and long-term results.

M Shabtai1, M Ben-Haim, Y Muntz, I Vered, D Rosin, J Kuriansky, O Zmora, D Olchovski, A Ayalon, S T Zwas.   

Abstract

BACKGROUND: The advent of highly accurate parathyroid imaging and the ever-increasing trend towards minimally invasive procedures have changed considerably the surgical approach to the patient with primary hyperparathyroidism (PHPT) caused by a single parathyroid adenoma. This study analyzes the short- and longer-term results of 140 patients who underwent minimally invasive, radio-guided parathyroidectomy.
METHODS: Demographic, clinical, and pre-operative imaging data, operative findings, and short- and long-term results of 140 consecutive patients operated within a 20 months period (8/1999-4/2002), were prospectively entered into a database. Immediate pre-operative sestamibi scintigraphy with skin marking of focal adenoma uptake were followed by intraoperative hand-held gamma probe for the removal of the parathyroid adenoma by unilateral minimal access surgery. Preoperative and surgical data were analyzed and correlated to outcomes, measured by success or failure to cure PHPT, associated morbidity and mortality, predictive value of localizing studies, and postoperative laboratory results in the immediate as well as long-term period.
RESULTS: 140 patients, mean age: 55.1 +/- 14.1 years (range 19-88 years), female to male ratio 94:46 with PHPT proven by concomitantly elevated serum calcium and parathormone (PTH) levels, with a single adenoma identified by sestamibi single photon emission tomography (SPECT) scintigraphy and high-resolution sonography, underwent minimally invasive, radio-guided parathyroidectomy. Mean serum levels of preoperative calcium, phosphorus, and PTH were 11.6 +/- 0.8 mg/dL (range 9.1-14), 3.0 +/- 0.3 mg/dL, and 147.1 +/- 94.3 pg/mL (range 68-784), respectively. Overall, in 3 out of 140 patients (2.1%), focused, minimally invasive surgery failed to identify and remove the adenoma. Positive predictive value when both localizing modalities concurred was 99.2%. Positive predictive value of SPECT scan alone was 97.2%. Overall success rate was 97.8% (137/140). 24 hours postoperative mean serum calcium was 9.2 +/- 0.8 mg/dL and at 6 months mean serum calcium, phosphorus, and PTH were 9.4 +/- 1.06 mg/dL, 3.2 +/- 0.8 mg/dL, and 32.1 +/- 11.9 pg/mL, respectively (p = 0.0001). There was no mortality. In 2 patients (1.4%) there was transient vocal cord paresis and there were 8 instances of clinically significant hypocalcemia. In 3 cases (2.1%), a second adenoma manifested itself 9-14 months following surgery and was removed by minimal access procedure.
CONCLUSIONS: Minimally invasive, radio-guided focused parathyroidectomy for a single adenoma is safe and effective in curing hyperparathyroidism with a 97% success rate. A second adenoma occurring in less than 3% may be successfully treated with a second minimal access operation. The combined positive predictive value of concurring sestamibi SPECT scintigraphy and sonography of 99.2% may increase success rate, and thus implementing this technique in patients with concurring sonography and scintigraphy may be advocated.

Entities:  

Mesh:

Year:  2003        PMID: 12618931     DOI: 10.1007/s00464-002-9198-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  24 in total

1.  Minimally invasive parathyroidectomy for primary hyperparathyroidism: decreasing operative time and potential complications while improving cosmetic results.

Authors:  J Norman; H Chheda; C Farrell
Journal:  Am Surg       Date:  1998-05       Impact factor: 0.688

2.  Concise parathyroidectomy: the impact of preoperative SPECT 99mTc sestamibi scanning and intraoperative quick parathormone assay.

Authors:  S E Carty; J Worsey; M A Virji; M L Brown; C G Watson
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

3.  Surgical management of hyperparathyroidism in view of a reliable parathyroid adenoma localization test.

Authors:  H Takami
Journal:  Surgery       Date:  1997-07       Impact factor: 3.982

4.  Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements.

Authors:  G N Sfakianakis; G L Irvin; J Foss; W Mallin; M Georgiou; G T Deriso; A S Molinari; S Ezuddin; W Ganz; A Serafini; A M Jabir; S K Chandarlapaty
Journal:  J Nucl Med       Date:  1996-05       Impact factor: 10.057

5.  One hundred consecutive minimally invasive parathyroid explorations.

Authors:  R Udelsman; P I Donovan; L J Sokoll
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

6.  Minimally invasive surgery for primary hyperparathyroidism: systematic review.

Authors:  T S Reeve; W J Babidge; R F Parkyn; A J Edis; L W Delbridge; P G Devitt; G J Maddern
Journal:  Arch Surg       Date:  2000-04

7.  99mTc-MIBI radio-guided minimally invasive parathyroidectomy: experience with patients with normal thyroids and nodular goiters.

Authors:  Dario Casara; Domenico Rubello; Cristina Cauzzo; Maria Rosa Pelizzo
Journal:  Thyroid       Date:  2002-01       Impact factor: 6.568

8.  Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123.

Authors:  E Hindié; D Mellière; C Jeanguillaume; L Perlemuter; F Chéhadé; P Galle
Journal:  J Nucl Med       Date:  1998-06       Impact factor: 10.057

9.  Unilateral parathyroidectomy in hyperparathyroidism due to single adenoma.

Authors:  S Tibblin; A G Bondeson; O Ljungberg
Journal:  Ann Surg       Date:  1982-03       Impact factor: 12.969

10.  Minimally invasive radioguided parathyroidectomy in the reoperative neck.

Authors:  J Norman; D Denham
Journal:  Surgery       Date:  1998-12       Impact factor: 3.982

View more
  8 in total

1.  Half-time SPECT acquisition with resolution recovery for Tc-MIBI SPECT imaging in the assessment of hyperparathyroidism.

Authors:  Ronen Bar; Kinga Przewloka; Rachel Karry; Alex Frenkel; Avishay Golz; Zohar Keidar
Journal:  Mol Imaging Biol       Date:  2012-10       Impact factor: 3.488

2.  Minimally invasive parathyroidectomy without using intraoperative parathyroid hormone monitoring or gamma probe.

Authors:  Aykut Soyder; Mustafa Ünübol; İmran Kurt Ömürlü; Engin Güney; Serdar Özbaş
Journal:  Ulus Cerrahi Derg       Date:  2015-03-01

3.  Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy.

Authors:  Raghunandan Venkat; Guennadi Kouniavsky; Ralph P Tufano; Eric B Schneider; Alan P B Dackiw; Martha A Zeiger
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

Review 4.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

5.  Exposure of surgical staff in surgical probe applications in radioguided parathyroidectomy.

Authors:  Recep Bekiş; Pinar Celik; Banu Uysal; Mehmet Ali Koçdor; Koray Atila; Serdar Saydam; Omer Harmancioğlu; Hatice Durak
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-10       Impact factor: 2.503

6.  Primary hyperparathyroidism patients with positive preoperative sestamibi scan and negative ultrasound are more likely to have posteriorly located upper gland adenomas (PLUGs).

Authors:  Avital Harari; Elliot Mitmaker; Raymon H Grogan; James Lee; Wen Shen; Jessica Gosnell; Orlo Clark; Quan-Yang Duh
Journal:  Ann Surg Oncol       Date:  2011-01-05       Impact factor: 5.344

7.  Intraoperative scintigraphy using a large field-of-view portable gamma camera for primary hyperparathyroidism: initial experience.

Authors:  Nathan C Hall; Robert L Plews; Amit Agrawal; Stephen P Povoski; Chadwick L Wright; Jun Zhang; Edward W Martin; John Phay
Journal:  Biomed Res Int       Date:  2015-01-06       Impact factor: 3.411

8.  Radioguided Parathyroidectomy with Portable Mini Gamma-Camera for the Treatment of Primary Hyperparathyroidism.

Authors:  Claudio Casella; Pierluigi Rossini; Carlo Cappelli; Chiara Nessi; Riccardo Nascimbeni; Nazario Portolani
Journal:  Int J Endocrinol       Date:  2015-09-15       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.